Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

Y0000165

Tribenoside

European Pharmacopoeia (EP) Reference Standard

Synonym(s):

Ethyl 3,5,6-tri-O-benzyl-D-glucofuranoside

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C29H34O6
CAS Number:
10310-32-4
Molecular Weight:
478.58
EC Number:
233-687-2
UNSPSC Code:
41116107
NACRES:
NA.24

grade

pharmaceutical primary standard

API family

tribenoside

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

shipped in

wet ice

storage temp.

−20°C

InChI

1S/C29H34O6/c1-2-32-29-26(30)28(34-20-24-16-10-5-11-17-24)27(35-29)25(33-19-23-14-8-4-9-15-23)21-31-18-22-12-6-3-7-13-22/h3-17,25-30H,2,18-21H2,1H3/t25?,26-,27-,28-,29?/m1/s1

InChI key

ULLNJSBQMBKOJH-NUZMXOBKSA-N

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Tribenoside EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

Storage Class

11 - Combustible Solids

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Glyvenol therapy in varicose veins an evaluation of its effectiveness.
I Kakande
East African medical journal, 58(7), 532-538 (1981-07-01)
D A Kalbhen et al.
The Journal of rheumatology, 10(2), 267-281 (1983-04-01)
Experiments in adult hens with chemically induced osteoarthrosis or osteoarthritis (OA) of the knee joint have shown that daily treatment with tribenoside (Glyvenol) in single oral doses of 50 mg/kg or 150 mg/kg markedly reduced the intensity and frequency of
Tamás Kubicsek et al.
Reproductive toxicology (Elmsford, N.Y.), 31(4), 464-469 (2010-12-25)
Tribenoside is used for the treatment of haemorrhoids and varicose veins, frequently in pregnant women as well, but published data regarding its possible teratogenic effect are not available. Thus the risk of congenital abnormalities (CAs) was estimated in cases of
[Test of potential antiarthritic drugs on spontaneous arthritis of mice].
G Wilhelmi et al.
Zeitschrift fur Rheumatologie, 42(4), 203-205 (1983-07-01)
L A Chaĭka et al.
Farmakologiia i toksikologiia, 44(1), 74-77 (1981-01-01)
A study was made on the mechanism of action of the antivaricose agent tribenol (ethyl-3,5,6-tri-O-benzyl-D-glucofuranozide; glivenol) on the activity of hydroxyreductase on the Krebs cycle and glycolysis during occlusion of the femoral vein and its inflammation in rats. It was
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service